Advertisement

IL-2, the next best thing in chronic GVHD therapy?

Lauren M. Curtis and Steven Z. Pavletic

Article Figures & Data

Figures

  • IL-2 induces both Treg expansion and an increase in the median Treg:Tcon ratio, which subsequently decreases when IL-2 therapy is withdrawn. NR, nonresponder; R, responder. See Figure 2A-B in the article by Koreth et al that begins on page 130.